Nature’s Sunshine (NATR) Products announced the launch of an underwritten secondary public offering of up to 2.85M shares of its common stock to be sold by Fosun Pharma USA. The selling stockholder will receive all of the net proceeds from the offering. D.A. Davidson & Co. is acting as sole book-running manager and representative of the underwriters for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NATR:
- Nature’s Sunshine files to sell 2.85M shares of common stock for holders
- Nature’s Sunshine Products: Strategic Leadership Transition and Strong Financial Outlook Support Buy Rating
- Nature’s Sunshine CEO Terrence Moorehead Steps Down
- Nature’s Sunshine CEO Terrence Moorehead to step down
- Nature’s Sunshine Products Shines in 2025 Earnings Call